REM Sleep Behavior Disorder and other sleep abnormalities in p. A53T SNCA mutation carriers.

@article{Simitsi2020REMSB,
  title={REM Sleep Behavior Disorder and other sleep abnormalities in p. A53T SNCA mutation carriers.},
  author={A. Simitsi and C. Koros and M. Stamelou and D. Papadimitriou and Athanasios Leonardos and A. Bougea and N. Papagiannakis and I. Pachi and Efthalia Angelopoulou and Konstantinos Lourentzos and A. Bonakis and L. Stefanis},
  journal={Sleep},
  year={2020}
}
STUDY OBJECTIVES Τo assess whether REM Sleep Behavior Disorder (RBD) and other sleep abnormalities occur in carriers of the p.A53T alpha-synuclein gene (SNCA) mutation, using both subjective and objective measures. METHODS We have assessed 15 p.A53T carriers [10 manifesting Parkinson's Disease (PD-A53T) and 5 asymptomatic carriers] with simultaneous Video-PSG (polysomnography) recording, the Epworth Sleepiness Scale (ESS) for daytime sleepiness, the Athens Insomnia Scale (AIS), the RBD… Expand

References

SHOWING 1-10 OF 41 REFERENCES
REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease
TLDR
RBD and REM sleep without atonia are frequent in PD as shown by PSG recordings, and their cases may represent preclinical forms of RBD associated with PD. Expand
Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers
TLDR
Sleep complaints are frequent in LRRK2-PD and show a pattern that when compared to IPD is characterized by more frequent sleep onset insomnia, similar EDS and less prominent RBD, whereas in IPD, RBD and EDS seem to be not markers of the prodromal stage of L RRK 2-PD. Expand
REM sleep‐associated motor behaviors in Parkinson's disease patients with heterozygous Parkin mutations
TLDR
It is concluded that mutations in the Parkin gene do not protect Parkinson’s disease patients from the emergence of RBD in the course of the disease, and behavioral events in REM sleep without a substantial amount of RWA are demonstrated. Expand
Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study
TLDR
It is indicated that in people presenting to sleep centres, RBD often antedates the development of a neurodegenerative disorder, which may be of great interest when early effective treatment strategies and neuroprotective drugs become available. Expand
SNCA Hypomethylation in Rapid Eye Movement Sleep Behavior Disorder Is a Potential Biomarker for Parkinson's Disease.
TLDR
SNCA hypomethylation in leukocytes existed both in patients with iRBD and those with PD, indicating that SNCA methylation could be a potential biomarker for early PD diagnosis. Expand
The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson's disease
TLDR
It is suggested that olfactory dysfunction and RBD might relate to prognosis in patients with PD, and patients who have both hyposmia and R BD were more likely to exhibit cognitive dysfunction. Expand
Idiopathic REM sleep behaviour disorder and neurodegeneration — an update
TLDR
An update on classic and novel biomarkers of α-synuclein-related neurodegeneration in patients with idiopathic RBD, focusing on advances in imaging and neurophysiological, cognitive, autonomic, tissue-specific and other biomarkers. Expand
Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson’s disease: a genetic association study
TLDR
Findings provide proof of principle that a largely stable, dichotomous clinical feature of Parkinson’s disease can be linked to a specific genetic susceptibility profile and support the hypothesis of RBD as relevant marker for a distinct subtype of the disorder. Expand
The Role of the Serotonergic System in REM Sleep Behavior Disorder.
TLDR
The results suggest that the serotonergic system is not directly involved in RBD pathogenesis while confirming nigro-striatal dopaminergic deafferentation in iRBD. Expand
Normative EMG values during REM sleep for the diagnosis of REM sleep behavior disorder.
TLDR
For the diagnosis of iRBD and RBD associated with PD, a polysomnographic montage quantifying "any" (any type of EMG activity, irrespective of whether it consisted of tonic, phasic or a combination of both) is recommended. Expand
...
1
2
3
4
5
...